Načítá se...
Positive Allosteric Modulators of Metabotropic Glutamate 2 Receptors in Schizophrenia Treatment
The last two decades have witnessed a rise in the “NMDA receptor hypofunction” hypothesis for schizophrenia, a devastating disorder that affects around 1% of the population worldwide. A variety of presynaptic, postsynaptic and regulatory proteins involved in glutamatergic signaling have thus been pr...
Uloženo v:
| Vydáno v: | Trends Neurosci |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530036/ https://ncbi.nlm.nih.gov/pubmed/26148747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tins.2015.06.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|